8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Apr 1, 2026·SEC
Material company update
Mar 12, 2026·SEC
iRhythm Technologies, Inc.(IRTC)Earnings, Financials & Key Ratios
IRTC•NASDAQ
Price updated Jun 19, 2026
AboutiRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Show more
- Revenue$747M+26.2%
- EBITDA-$10M+88.5%
- Net Income-$45M+60.7%
- EPS (Diluted)-1.39+61.7%
- Gross Margin70.57%+2.5%
- EBITDA Margin-1.38%+90.9%
- Operating Margin-4.93%+74.8%
- Net Margin-5.96%+68.8%
- ROE-36.57%+51.4%
IRTC Key Insights
iRhythm Technologies, Inc. (IRTC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 23.0%
✗Weaknesses
- ✗High debt to equity ratio of 4.8x
- ✗Weak momentum: RS Rating 16 (bottom 16%)
- ✗Trading more than 30% below 52-week high
- ✗Expensive at 21.9x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when IRTC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
IRTC Price & Volume
iRhythm Technologies, Inc. (IRTC) stock price & volume — 10-year historical chart
Loading chart...
IRTC Growth Metrics
iRhythm Technologies, Inc. (IRTC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years35.38%
5 Years23.02%
3 Years22.05%
TTM27.36%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM71.74%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM72.63%
Return on Capital
10 Years-24.96%
5 Years-23.28%
3 Years-20.35%
Last Year-4.36%
IRTC Recent Earnings
iRhythm Technologies, Inc. (IRTC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$0.35+37.5%
$0.56
Rev
$199M+2.7%
$194M
Q1 2026
Feb 19, 2026Metric
Actual
Est
EPS
$0.17+750.0%
$0.02
Rev
$209M+3.5%
$202M
Q4 2025
Oct 30, 2025Metric
Actual
Est
EPS
$0.06+83.3%
$0.36
Rev
$193M-4.4%
$202M
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$0.32+39.6%
$0.53
Rev
$187M+6.4%
$176M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $0.35vs $0.56+37.5% | $199Mvs $194M+2.7% |
| Q1 2026 | Feb 19, 2026 | $0.17vs $0.02+750.0% | $209Mvs $202M+3.5% |
| Q4 2025 | Oct 30, 2025 | $0.06vs $0.36+83.3% | $193Mvs $202M-4.4% |
| Q3 2025 | Jul 31, 2025 | $0.32vs $0.53+39.6% | $187Mvs $176M+6.4% |
Based on last 12 quarters of dataView full earnings history →
IRTC Peer Comparison
iRhythm Technologies, Inc. (IRTC) competitors in Patient monitoring and wearable diagnostics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ITGR | 3.13B | 90.96 | 31.47 | 7.57% | 7.67% | 8.23% | 0.80 | |
 INVA | 1.66B | 22.49 | 6.82 | 18.52% | 118.91% | 47.59% | 0.23 | |
 BDX | 52.16B | 143.98 | 24.70 | 8.23% | 5.33% | 4.54% | 0.76 | |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 11.01% | 0.52 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 MDT | 101.86B | 79.34 | 21.98 | 3.62% | 13% | 9.49% | 0.59 | |
 ABT | 153.68B | 88.38 | 11.57 | 4.59% | 31.88% | 27.26% | 0.32 | |
 BSX | 67.31B | 45.29 | 23.35 | 19.87% | 14.4% | 12.4% | 0.51 |
Compare IRTC vs Peers
iRhythm Technologies, Inc. (IRTC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
IRTC Income Statement
iRhythm Technologies, Inc. (IRTC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 99.13M | 147.28M | 214.55M | 265.17M | 322.82M | 410.92M | 492.68M | 591.84M | 747.14M | 787.85M |
Revenue Growth % | 54.72% | 48.57% | 45.68% | 23.59% | 21.74% | 27.29% | 19.9% | 20.13% | 26.24% | 27.36% |
Cost of Goods Sold | 28.2M | 38.8M | 52.48M | 70.28M | 109.26M | 129.29M | 160.88M | 184.31M | 219.89M | 228.46M |
COGS % of Revenue | 28.45% | 26.34% | 24.46% | 26.5% | 33.84% | 31.46% | 32.65% | 31.14% | 29.43% | - |
Gross Profit | 70.93M▲ 0% | 108.48M▲ 53.0% | 162.07M▲ 49.4% | 194.89M▲ 20.3% | 213.57M▲ 9.6% | 281.63M▲ 31.9% | 331.81M▲ 17.8% | 407.53M▲ 22.8% | 527.25M▲ 29.4% | 559.39M▲ 0% |
Gross Margin % | 71.55% | 73.66% | 75.54% | 73.5% | 66.16% | 68.54% | 67.35% | 68.86% | 70.57% | 71% |
Gross Profit Growth % | 64.22% | 52.95% | 49.4% | 20.25% | 9.58% | 31.87% | 17.82% | 22.82% | 29.38% | - |
Operating Expenses | 98.52M | 154.17M | 216.82M | 238.56M | 313.51M | 395.42M | 456.97M | 523.04M | 564.06M | 585.04M |
OpEx % of Revenue | 99.38% | 104.68% | 101.06% | 89.97% | 97.11% | 96.23% | 92.75% | 88.37% | 75.5% | - |
Selling, General & Admin | 85.25M | 133.31M | 179.52M | 197.23M | 274.84M | 322.2M | 385.64M | 418.56M | 479.45M | 500.59M |
SG&A % of Revenue | 86% | 90.52% | 83.67% | 74.38% | 85.14% | 78.41% | 78.27% | 70.72% | 64.17% | - |
Research & Development | 13.27M | 20.86M | 37.3M | 41.33M | 38.67M | 46.61M | 60.24M | 103.83M | 84.61M | 84.45M |
R&D % of Revenue | 13.38% | 14.16% | 17.38% | 15.59% | 11.98% | 11.34% | 12.23% | 17.54% | 11.32% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 26.61M | 11.08M | 641K | 0 | 0 |
Operating Income | -27.59M▲ 0% | -45.69M▼ 65.6% | -54.76M▼ 19.8% | -43.67M▲ 20.2% | -99.94M▼ 128.8% | -113.78M▼ 13.8% | -125.16M▼ 10.0% | -115.5M▲ 7.7% | -36.81M▲ 68.1% | -25.95M▲ 0% |
Operating Margin % | -27.83% | -31.02% | -25.52% | -16.47% | -30.96% | -27.69% | -25.4% | -19.52% | -4.93% | -3.29% |
Operating Income Growth % | -77.07% | -65.6% | -19.84% | 20.24% | -128.84% | -13.85% | -10% | 7.71% | 68.13% | - |
EBITDA | -25.99M | -43.42M | -51.31M | -30.74M | -83.35M | -94.17M | -103.02M | -89.73M | -10.33M | -6.08M |
EBITDA Margin % | -26.22% | -29.48% | -23.91% | -11.59% | -25.82% | -22.92% | -20.91% | -15.16% | -1.38% | -0.77% |
EBITDA Growth % | -73.13% | -67.05% | -18.17% | 40.08% | -171.12% | -12.99% | -9.39% | 12.9% | 88.49% | 92.74% |
D&A (Non-Cash Add-back) | 1.6M | 2.27M | 3.44M | 12.93M | 16.59M | 19.61M | 22.14M | 25.78M | 26.48M | 19.88M |
EBIT | -26.35M | -47.22M | -52.86M | -42.08M | -99.83M | -111.75M | -119.01M | -99.9M | -36.81M | -9.77M |
Net Interest Income | -3.39M | -3.12M | -1.64M | -1.52M | -1.05M | -1.79M | 2.5M | 9.12M | 8.37M | 6.72M |
Interest Income | 0 | 0 | 0 | 0 | 118K | 2.35M | 6.16M | 21.94M | 21.52M | 21.48M |
Interest Expense | 3.39M | 3.12M | 1.64M | 1.52M | 1.17M | 4.14M | 3.65M | 12.82M | 13.15M | 6.59M |
Other Income/Expense | -2.15M | -4.64M | 252K | 72K | -1.05M | -2.1M | 2.5M | 2.78M | -6.79M | -1.04M |
Pretax Income | -29.74M▲ 0% | -50.33M▼ 69.2% | -54.5M▼ 8.3% | -43.6M▲ 20.0% | -100.99M▼ 131.6% | -115.89M▼ 14.7% | -122.66M▼ 5.8% | -112.72M▲ 8.1% | -43.6M▲ 61.3% | -27M▲ 0% |
Pretax Margin % | -30% | -34.18% | -25.4% | -16.44% | -31.28% | -28.2% | -24.9% | -19.05% | -5.84% | -3.43% |
Income Tax | 0 | 44K | 65K | 229K | 367K | 269K | 750K | 565K | 953K | 788K |
Effective Tax Rate % | 0% | -0.09% | -0.12% | -0.53% | -0.36% | -0.23% | -0.61% | -0.5% | -2.19% | -2.92% |
Net Income | -29.74M▲ 0% | -50.38M▼ 69.4% | -54.57M▼ 8.3% | -43.83M▲ 19.7% | -101.36M▼ 131.3% | -116.16M▼ 14.6% | -123.41M▼ 6.2% | -113.29M▲ 8.2% | -44.55M▲ 60.7% | -27.78M▲ 0% |
Net Margin % | -30% | -34.21% | -25.43% | -16.53% | -31.4% | -28.27% | -25.05% | -19.14% | -5.96% | -3.53% |
Net Income Growth % | -42.28% | -69.39% | -8.32% | 19.68% | -131.26% | -14.6% | -6.24% | 8.2% | 60.67% | 71.74% |
Net Income (Continuing) | -29.74M | -50.38M | -54.57M | -43.83M | -101.36M | -116.16M | -123.41M | -113.29M | -44.55M | -27.78M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -1.30▲ 0% | -2.02▼ 55.4% | -2.16▼ 6.9% | -1.58▲ 26.9% | -3.46▼ 119.0% | -3.88▼ 12.1% | -4.04▼ 4.1% | -3.63▲ 10.1% | -1.39▲ 61.7% | -0.85▲ 0% |
EPS Growth % | 67.09% | -55.38% | -6.93% | 26.85% | -118.99% | -12.14% | -4.12% | 10.15% | 61.71% | 72.63% |
EPS (Basic) | -1.30 | -2.02 | -2.16 | -1.58 | -3.46 | -3.88 | -4.04 | -3.63 | -1.39 | - |
Diluted Shares Outstanding | 22.63M | 23.89M | 25.27M | 27.75M | 29.33M | 29.92M | 30.53M | 31.2M | 32M | 32.51M |
Basic Shares Outstanding | 22.63M | 23.89M | 25.27M | 27.75M | 29.33M | 29.92M | 30.53M | 31.2M | 32M | 32.51M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
IRTC Balance Sheet
iRhythm Technologies, Inc. (IRTC) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 119.58M | 106.48M | 172.79M | 377.82M | 305.52M | 288.77M | 230.81M | 645.82M | 702.76M | 680.56M |
Cash & Short-Term Investments | 102.36M | 78.34M | 140.55M | 335.22M | 239.13M | 213.14M | 133.76M | 535.55M | 583.76M | 549.62M |
Cash Only | 8.67M | 20.02M | 20.46M | 88.63M | 127.56M | 78.83M | 36.17M | 419.6M | 236.01M | 240.15M |
Short-Term Investments | 93.69M | 58.32M | 120.09M | 246.59M | 111.57M | 134.31M | 97.59M | 115.96M | 347.75M | 309.47M |
Accounts Receivable | 12.95M | 19.79M | 23.87M | 29.93M | 46.43M | 49.92M | 61.48M | 79.94M | 75.71M | 80.86M |
Days Sales Outstanding | 47.69 | 49.05 | 40.6 | 41.2 | 52.5 | 44.34 | 45.55 | 49.3 | 36.98 | 36.47 |
Inventory | 1.68M | 2.06M | 4.04M | 5.31M | 10.27M | 15.15M | 13.97M | 14.04M | 21.63M | 23.8M |
Days Inventory Outstanding | 21.78 | 19.4 | 28.07 | 27.59 | 34.3 | 42.78 | 31.7 | 27.8 | 35.91 | 33.31 |
Other Current Assets | 2.58M | 4.1M | 4.34M | 7.36M | 9.69M | 10.55M | 21.59M | 16.29M | 21.66M | 26.27M |
Total Non-Current Assets | 13.54M | 13.23M | 133.42M | 133.91M | 157.44M | 159.45M | 202.33M | 285.63M | 317.28M | 325.81M |
Property, Plant & Equipment | 6.22M | 9.16M | 116.59M | 118.96M | 140.53M | 136.34M | 153.43M | 172.66M | 193.43M | 197.03M |
Fixed Asset Turnover | 15.93x | 16.08x | 1.84x | 2.23x | 2.30x | 3.01x | 3.21x | 3.43x | 3.86x | 4.11x |
Goodwill | 862K | 862K | 862K | 862K | 862K | 862K | 862K | 862K | 862K | 862K |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 2.99M | 0 | 8.03M | 0 | 0 | 0 | 3M | 61.9M | 69.91M | 275.76M |
Other Non-Current Assets | 3.46M | 3.21M | 7.94M | 14.09M | 16.05M | 22.25M | 45.04M | 50.21M | 53.08M | 55.06M |
Total Assets | 133.12M▲ 0% | 119.71M▼ 10.1% | 306.21M▲ 155.8% | 511.74M▲ 67.1% | 462.97M▼ 9.5% | 448.22M▼ 3.2% | 433.14M▼ 3.4% | 931.45M▲ 115.0% | 1.02B▲ 9.5% | 1.01B▲ 0% |
Asset Turnover | 0.74x | 1.23x | 0.70x | 0.52x | 0.70x | 0.92x | 1.14x | 0.64x | 0.73x | 0.79x |
Asset Growth % | -3.64% | -10.08% | 155.79% | 67.12% | -9.53% | -3.18% | -3.36% | 115.04% | 9.51% | 32.46% |
Total Current Liabilities | 20.92M | 30.24M | 52.07M | 65.67M | 87.85M | 89.1M | 107.37M | 110.92M | 151.89M | 131.75M |
Accounts Payable | 2.4M | 2.28M | 8.24M | 4.37M | 10.51M | 7.52M | 5.54M | 7.22M | 2.26M | 8.56M |
Days Payables Outstanding | 31 | 21.49 | 57.32 | 22.67 | 35.11 | 21.22 | 12.58 | 14.3 | 3.74 | 12.73 |
Short-Term Debt | 1.49M | 0 | 1.94M | 11.67M | 11.67M | 0 | 0 | 0 | 16.69M | 16.79M |
Deferred Revenue (Current) | 1.24M | 1.24M | 1.25M | 930K | 3.05M | 3.05M | 3.31M | 2.93M | 4.2M | 15.98M |
Other Current Liabilities | 1.38M | 5.81M | 9.75M | 13.96M | 8.57M | 18.7M | 1.04M | 35.11M | 128.75M | 102.34M |
Current Ratio | 5.72x | 3.52x | 3.32x | 5.75x | 3.48x | 3.24x | 2.15x | 5.82x | 4.63x | 5.17x |
Quick Ratio | 5.64x | 3.45x | 3.24x | 5.67x | 3.36x | 3.07x | 2.02x | 5.70x | 4.48x | 4.98x |
Cash Conversion Cycle | 38.48 | 46.96 | 11.35 | 46.12 | 51.69 | 65.9 | 64.68 | 62.8 | 69.15 | 57.05 |
Total Non-Current Liabilities | 32.65M | 35.05M | 118.74M | 104.46M | 95.6M | 119.31M | 115.68M | 729.62M | 715.41M | 713.4M |
Long-Term Debt | 32.49M | 34.9M | 32.99M | 21.34M | 9.69M | 34.94M | 34.95M | 646.44M | 714.5M | 712.5M |
Capital Lease Obligations | 0 | 0 | 85.75M | 81.29M | 85.21M | 83.07M | 79.72M | 74.6M | 0 | 70.38M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 161K | 153K | 0 | 1.83M | 697K | 1.31M | 1.01M | 8.58M | 908K | 907K |
Total Liabilities | 53.57M | 65.29M | 170.8M | 170.13M | 183.45M | 208.41M | 223.05M | 840.54M | 867.3M | 845.15M |
Total Debt | 33.98M | 34.9M | 128.59M | 122.47M | 117.71M | 131.04M | 129.82M | 736.91M | 731.18M | 729.29M |
Net Debt | 25.31M | 14.88M | 108.13M | 33.84M | -9.85M | 52.21M | 93.65M | 317.31M | 495.17M | 489.14M |
Debt / Equity | 0.43x | 0.64x | 0.95x | 0.36x | 0.42x | 0.55x | 0.62x | 8.11x | 4.79x | 4.52x |
Debt / EBITDA | - | - | - | - | - | - | - | - | - | -120.05x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -80.52x |
Interest Coverage | -7.78x | -15.16x | -32.17x | -27.70x | -85.39x | -27.01x | -32.60x | -7.79x | -2.80x | -1.48x |
Total Equity | 79.55M▲ 0% | 54.42M▼ 31.6% | 135.41M▲ 148.8% | 341.61M▲ 152.3% | 279.51M▼ 18.2% | 239.81M▼ 14.2% | 210.1M▼ 12.4% | 90.91M▼ 56.7% | 152.75M▲ 68.0% | 161.21M▲ 0% |
Equity Growth % | -14.05% | -31.59% | 148.81% | 152.28% | -18.18% | -14.2% | -12.39% | -56.73% | 68.02% | 228.39% |
Book Value per Share | 3.52 | 2.28 | 5.36 | 12.31 | 9.53 | 8.02 | 6.88 | 2.91 | 4.77 | 4.96 |
Total Shareholders' Equity | 79.55M | 54.42M | 135.41M | 341.61M | 279.51M | 239.81M | 210.1M | 90.91M | 152.75M | 161.21M |
Common Stock | 23K | 23K | 25K | 27K | 27K | 28K | 31K | 31K | 32K | 33K |
Retained Earnings | -156.59M | -203.51M | -260.39M | -304.68M | -406.05M | -522.2M | -645.61M | -758.89M | -803.45M | -817.38M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25M | 0 | 0 |
Accumulated OCI | -65K | -41K | 82K | 11K | -61K | -396K | -112K | 165K | 403K | 42K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IRTC Cash Flow Statement
iRhythm Technologies, Inc. (IRTC) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -14.91M | -29.07M | -21.86M | -13.76M | -37.75M | -23.01M | -50.1M | 3.39M | 80.86M | 62.58M |
Operating CF Margin % | -15.04% | -19.74% | -10.19% | -5.19% | -11.69% | -5.6% | -10.17% | 0.57% | 10.82% | - |
Operating CF Growth % | 10.45% | -94.94% | 24.79% | 37.07% | -174.39% | 39.05% | -117.72% | 106.77% | 2285.34% | -18.51% |
Net Income | -29.42M | -48.28M | -54.57M | -43.83M | -101.36M | -116.16M | -123.41M | 0 | -44.55M | -27.78M |
Depreciation & Amortization | 1.6M | 2.27M | 3.44M | 6.9M | 16.59M | 19.61M | 22.14M | 0 | 0 | 22.11M |
Stock-Based Compensation | 10.12M | 16.33M | 26.24M | 41.52M | 54.53M | 57.74M | 77.2M | 0 | 0 | 65.32M |
Deferred Taxes | 9.06M | 17.41M | 23.76M | 31.86M | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 1.81M | -2.93M | 8.99M | 6.03M | 38.72M | 81.3M | 76M | 102.51M | 217.11M | 58.33M |
Working Capital Changes | -8.08M | -13.87M | -29.73M | -56.23M | -46.23M | -65.51M | -102.05M | -99.12M | -91.7M | -55.4M |
Change in Receivables | -12.95M | -22.89M | -28.73M | -37.96M | -53.57M | -61.84M | -81.19M | -91.92M | -95.43M | -98.31M |
Change in Inventory | -293K | -380K | -1.97M | -1.39M | -4.96M | -5.11M | 979K | -224K | -8.51M | -10.55M |
Change in Payables | 634K | -192K | 5.6M | -3.88M | 6.13M | -2.99M | -1.97M | -7.41M | 28.04M | -9M |
Cash from Investing | -34.59M | 34.12M | -89.27M | -132.39M | 105.26M | -52.43M | -1.21M | -122.98M | -277.06M | -208.7M |
Capital Expenditures | -3.56M | -5.18M | -20.46M | -13.55M | -28.07M | -29.83M | -40.42M | -33.94M | -46.34M | -43.83M |
CapEx % of Revenue | 3.59% | 3.52% | 9.53% | 5.11% | 8.69% | 7.26% | 8.2% | 5.73% | 6.2% | 5.56% |
Acquisitions | 0 | 0 | 68.82M | 118.84M | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 91K | 39.32M | -68.82M | -118.84M | 0 | 0 | 0 | -89.04M | 0 | 0 |
Cash from Financing | 6.53M | 6.3M | 111.58M | 214.32M | -28.58M | 26.72M | 8.82M | 511.38M | 12.61M | 11.03M |
Debt Issued (Net) | 0 | 3.5M | 0 | -1.94M | -11.67M | 13.53M | 0 | 619.84M | 0 | 0 |
Equity Issued (Net) | 6.39M | 0 | 107.37M | 206.03M | 8.94M | 0 | 0 | -25M | 12.61M | 10.05M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | -3.88M | 0 | 0 | 0 | 0 | 0 | -25M | 0 | 0 |
Other Financing | 142K | 2.8M | 4.21M | 10.23M | -25.85M | 13.18M | 8.82M | -83.46M | 0 | 974K |
Net Change in Cash | -42.97M▲ 0% | 11.35M▲ 126.4% | 439K▼ 96.1% | 68.17M▲ 15427.6% | 38.93M▼ 42.9% | -48.73M▼ 225.2% | -42.66M▲ 12.5% | 391.78M▲ 1018.4% | -183.59M▼ 146.9% | -135.13M▲ 0% |
Free Cash Flow | -18.47M▲ 0% | -34.25M▼ 85.4% | -42.32M▼ 23.6% | -27.31M▲ 35.5% | -65.82M▼ 141.0% | -52.84M▲ 19.7% | -90.53M▼ 71.3% | -30.55M▲ 66.3% | 34.52M▲ 213.0% | 18.75M▲ 0% |
FCF Margin % | -18.64% | -23.25% | -19.72% | -10.3% | -20.39% | -12.86% | -18.37% | -5.16% | 4.62% | 2.38% |
FCF Growth % | 4.85% | -85.39% | -23.57% | 35.47% | -141.01% | 19.72% | -71.31% | 66.25% | 212.99% | 34.5% |
FCF per Share | -0.82 | -1.43 | -1.67 | -0.98 | -2.24 | -1.77 | -2.97 | -0.98 | 1.08 | 0.58 |
FCF Conversion (FCF/Net Income) | 0.50x | 0.58x | 0.40x | 0.31x | 0.37x | 0.20x | 0.41x | -0.03x | -1.82x | -0.67x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 3.32M | 2.96M | 6.39M | 0 | 4.96M |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 287K | 1.13M | 923K | 0 | 546K |
IRTC Key Ratios
iRhythm Technologies, Inc. (IRTC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -34.56% | -75.21% | -57.49% | -18.38% | -32.64% | -44.73% | -54.86% | -75.27% | -36.57% | -20.6% |
Return on Invested Capital (ROIC) | -23.25% | -39.35% | -26.25% | -10.58% | -23.24% | -30.39% | -31.51% | -24.34% | -5.23% | -3.21% |
Gross Margin | 71.55% | 73.66% | 75.54% | 73.5% | 66.16% | 68.54% | 67.35% | 68.86% | 70.57% | 71% |
Net Margin | -30% | -34.21% | -25.43% | -16.53% | -31.4% | -28.27% | -25.05% | -19.14% | -5.96% | -3.53% |
Debt / Equity | 0.43x | 0.64x | 0.95x | 0.36x | 0.42x | 0.55x | 0.62x | 8.11x | 4.79x | 4.52x |
Interest Coverage | -7.78x | -15.16x | -32.17x | -27.70x | -85.39x | -27.01x | -32.60x | -7.79x | -2.80x | -1.48x |
FCF Conversion | 0.50x | 0.58x | 0.40x | 0.31x | 0.37x | 0.20x | 0.41x | -0.03x | -1.82x | -0.67x |
Revenue Growth | 54.72% | 48.57% | 45.68% | 23.59% | 21.74% | 27.29% | 19.9% | 20.13% | 26.24% | 27.36% |
Related:IRTC Dividend History·IRTC Revenue History·IRTC Price History·IRTC P/E History·IRTC Financial Ratios·IRTC Institutional Holders
IRTC SEC Filings & Documents
iRhythm Technologies, Inc. (IRTC) SEC filings — annual & quarterly reports (10-K, 10-Q)
IRTC Frequently Asked Questions
iRhythm Technologies, Inc. (IRTC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
iRhythm Technologies, Inc. (IRTC) reported $787.9M in revenue for fiscal year 2025. This represents a 5027% increase from $15.4M in 2013.
iRhythm Technologies, Inc. (IRTC) grew revenue by 26.2% over the past year. This is strong growth.
iRhythm Technologies, Inc. (IRTC) reported a net loss of $27.8M for fiscal year 2025.
Dividend & Returns
iRhythm Technologies, Inc. (IRTC) has a return on equity (ROE) of -36.6%. Negative ROE indicates the company is unprofitable.
iRhythm Technologies, Inc. (IRTC) generated $18.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.